Table 2.
Effect of the formulation on malondialdehyde and Total antioxidant capacity.
| Malondialdehyde (MDA) in μmol/L |
Total Antioxidant Capacity (TAC) in (mg EAA/g DM) |
||||
|---|---|---|---|---|---|
| Liver | Plasma | Pancreas | Heart | Pancreas | |
| SD | 7.84 ± 0.09¶ | 4.34 ± 0.04† | 3.79 ± 0.13† | 4.38 ± 0.01¶ | 4.09 ± 0.04¶ |
| HFHSD | 8.97 ± 0.06§ | 5.17 ± 0.12¶ | 3.94 ± 0.09† | 3.40 ± 0.02* | 1.88 ± 0.11* |
| HFHSD + F(1:1) | 6.95 ± 0.08† | 3.48 ± 0.48* | 2.42 ± 0.41* | 3.75 ± 0.03† | 2.65 ± 0.05† |
| HFHSD + Vit E | 1.41 ± 0.12* | 4.46 ± 0.02¶† | 4.03 ± 0.06† | 3.68 ± 0.02† | 2.75 ± 0.01† |
Results are expressed as mean ± standard error; EAA: equivalent ascorbic acid; DM: matter.
SD: standard diet; HFHSD: high fat high sucrose diet; vit E: vitamin E; values with different.
Symbols *, †, ¶, § in the same columns are significant (p < 0.05). F (1:1): represents 1 portion.
(weight) of A. sativum and 1 portion (weight) of P. americana.